Sudden cardiac death laboratory findings

Sudden cardiac death Microchapters
Home
Patient Information
Sudden Cardiac versus Non-Cardiac Death
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Definitions and Diagnosis
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Urgent Treatment
Post Arrest Care and Prevention
Ethical Issues
Sudden cardiac death laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sudden cardiac death laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sudden cardiac death laboratory findings
CDC on Sudden cardiac death laboratory findings
Sudden cardiac death laboratory findings in the news
Blogs on Sudden cardiac death laboratory findings
Directions to Hospitals Treating Sudden cardiac death
Risk calculators and risk factors for Sudden cardiac death laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Edzel Lorraine Co, DMD, MD[3]

Overview

Brain natriuretic peptide (BNP) or N-terminal pro-b-type-natriuretic peptide may have roles in the risk determination of patients for ventricular arrhythmia and sudden cardiac death.

Laboratory Findings

• An elevated concentration of brain natriuretic peptide(BNP) or N-terminal pro-b-type-natriuretic peptide has been shown to have roles in the SCD risk determination of patients .
• However, there is still a lack of sufficient evidence on the use of BNP as a method in the selection for the need of an implantable cardioverter defibrillators (ICD) .